EX-23.1 2 y18933a2exv23w1.txt EX-23.1: CONSENT OF KPMG LLP EXHIBIT 23.1 Consent of Independent Registered Public Accounting Firm The Board of Directors PTC Therapeutics, Inc: We consent to the use of our report dated March 31, 2006 with respect to the balance sheets of PTC Therapeutics, Inc. as of December 31, 2004 and 2005, and the related statements of operations, stockholders' equity (deficit) and comprehensive loss, and cash flows for each of the years in the three-year period ended December 31, 2005 and for the period from March 31, 1998 (inception) to December 31, 2005, included herein and to the reference to our firm under the heading "Experts" in the prospectus. /s/ KPMG LLP Philadelphia, Pennsylvania May 19, 2006